文献速递胸部肿瘤乳腺癌消化系统肿瘤

1990至2015年全球、区域及国家层面32个癌症组的发病率、死亡率、早逝寿命损失年、伤残损失寿命年及伤残调整寿命年:全球疾病负担研究的系统分析

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.
PubMed 文献 · JAMA Oncol · 2017-01-01

该研究基于全球疾病负担研究,估算1990至2015年195个国家和地区的32种癌症的死亡率、发病率、伤残损失寿命年、早逝寿命损失年和伤残调整寿命年。2005至2015年癌症病例增加33%,其中人口老龄化贡献16%、人口增长贡献13%、年龄别率变化贡献4%。男性最常见为前列腺癌,女性为乳腺癌;乳腺癌是女性癌症死亡和伤残调整寿命年的首位原因。

要点

  • 2005至2015年,195个国家中174个全癌年龄标化发病率上升,140个年龄标化死亡率下降。

核心结论

  • 随着流行病学转变,未来癌症发病率预计将增加,进一步加重有限的医疗资源压力。
  • GBD 2015研究结果表明,在抗击癌症的斗争中取得进展是可能的,但主要发现也突出显示了癌症预防工作(包括烟草控制、疫苗接种以及促进体育活动和健康饮食)存在未满足的需求。

研究设计与样本

  • 采用生命登记系统数据、癌症登记发病率数据(通过单独估算的死亡率与发病率比转化为死亡率估计)和口头尸检数据估算癌症死亡率。
  • 通过将死亡率估计除以建模的死亡率与发病率比计算癌症发病率;使用死亡率与发病率比建模生存率以计算患病率;患病率估计乘以残疾权重计算伤残损失寿命年;年龄别癌症死亡乘以参考期望寿命估算早逝寿命损失年;伤残调整寿命年为伤残损失寿命年与早逝寿命损失年之和。
  • 基于人均收入、教育程度和生育率创建社会人口指数,并按社会人口指数五分位数对国家进行分类汇总结果。

主要发现

  • 2005至2015年间,癌症病例增加33%,其中人口老龄化贡献16%、人口增长贡献13%、年龄别率变化贡献4%。

关键数值与推荐

  • 2005至2015年间,195个国家或地区中有174个全癌年龄标化发病率上升。
  • 2005至2015年间,195个国家或地区中有140个全癌年龄标化死亡率下降。
  • 全癌年龄标化死亡率上升的国家主要位于非洲大陆。
  • 2005至2015年间,霍奇金淋巴瘤死亡显著下降(-6.1% [95%不确定性区间,-10.6%至-1.3%])。
  • 食管癌、胃癌和慢性髓系白血病的死亡数也下降,但结果无统计学显著性。

临床怎么用

  • 癌症预防、早期诊断以及治愈性和姑息性治疗的适当资源分配需要详细了解当地癌症负担。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Cancer is the second leading cause of death worldwide. Current estimates on the burden of cancer are needed for cancer control planning. OBJECTIVE: To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 32 cancers in 195 countries and territories from 1990 to 2015. EVIDENCE REVIEW: Cancer mortality was estimated using vital registration system data, cancer registry incidence data (transformed to mortality estimates using separately estimated mortality to incidence [MI] ratios), and verbal autopsy data. Cancer incidence was calculated by dividing mortality estimates through the modeled MI ratios. To calculate cancer prevalence, MI ratios were used to model survival. To calculate YLDs, prevalence estimates were multiplied by disability weights. The YLLs were estimated by multiplying age-specific cancer deaths by the reference life expectancy. DALYs were estimated as the sum of YLDs and YLLs. A sociodemographic index (SDI) was created for each location based on income per capita, educational attainment, and fertility. Countries were categorized by SDI quintiles to summarize results. FINDINGS: In 2015, there were 17.5 million cancer cases worldwide and 8.7 million deaths. Between 2005 and 2015, cancer cases increased by 33%, with population aging contributing 16%, population growth 13%, and changes in age-specific rates contributing 4%. For men, the most common cancer globally was prostate cancer (1.6 million cases). Tracheal, bronchus, and lung cancer was the leading cause of cancer deaths and DALYs in men (1.2 million deaths and 25.9 million DALYs). For women, the most common cancer was breast cancer (2.4 million cases). Breast cancer was also the leading cause of cancer deaths and DALYs for women (523 000 deaths and 15.1 million DALYs). Overall, cancer caused 208.3 million DALYs worldwide in 2015 for both sexes combined. Between 2005 and 2015, age-standardized incidence rates for all cancers combined increased in 174 of 195 countries or territories. Age-standardized death rates (ASDRs) for all cancers combined decreased within that timeframe in 140 of 195 countries or territories. Countries with an increase in the ASDR due to all cancers were largely located on the African continent. Of all cancers, deaths between 2005 and 2015 decreased significantly for Hodgkin lymphoma (-6.1% [95% uncertainty interval (UI), -10.6% to -1.3%]). The number of deaths also decreased for esophageal cancer, stomach cancer, and chronic myeloid leukemia, although these results were not statistically significant. CONCLUSION AND RELEVANCE: As part of the epidemiological transition, cancer incidence is expected to increase in the future, further straining limited health care resources. Appropriate allocation of resources for cancer prevention, early diagnosis, and curative and palliative care requires detailed knowledge of the local burden of cancer. The GBD 2015 study results demonstrate that progress is possible in the war against cancer. However, the major findings also highlight an unmet need for cancer prevention efforts, including tobacco control, vaccination, and the promotion of physical activity and a healthy diet.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Fitzmaurice C, Allen C, Barber RM, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2017. PMID: 27918777. doi:10.1001/jamaoncol.2016.5688

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。